fun88 app ios

fun88 app iosLiên kết đăng nhập
fun88 app iosLiên kết đăng nhập
Media Room March 20, 2024

Statement by Sung Poblete, PhD, RN, CEO of FARE, Regarding AstraZeneca’s Decision to Cap the Cost of Inhalers

“At FARE, we applaud AstraZeneca’s decision to cap the cost of its inhalers, setting a standard for affordability in healthcare that we hope is emulated by other companies. Many in the asthma patient community also live with the disease of food allergy and so at the same time we offer these thanks, we urge the industry and government to do what is necessary to improve patient access to epinephrine auto-injectors by capping the cost in similar fashion so that those more than 33 million people in the US with food allergies can move more safely through the world and afford their medication.”

Media Contact: 

media@croixdefer.net


About FARE

FARE (Food Allergy Research & Education) is the nation’s leading non-profit engaged in food allergy advocacy and the largest food allergy charity supporting research. FARE’s innovative education, advocacy and research initiatives transform the future of food allergy through new and improved treatments and prevention strategies, effective policies and legislation, and novel approaches to managing the disease. To learn more, visit: croixdefer.net.

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.

fun88 sportsbook fun88 live casino m88 cá cược trực tuyến châu á cá cược trực tuyến trang cá cược trực tuyến